Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)

Clinical trial NCT04713059 · UNKNOWN

Trial details

NCT number: NCT04713059
Sponsor: The Affiliated Hospital of Qingdao University
Status: UNKNOWN
Study type: OBSERVATIONAL

Gastric or Gastro-oesophageal Junction Carcinoma Advanced, Relapsed Gastric or Gastro-oesophageal Junction Carcinoma Second-line Therapy

Start date: 2020-01-01
Primary completion: 2021-01-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.